Triggering receptor expressed on myeloid cells 2 (TREM2) is a protein that is primarily expressed in myeloid cell types in the brain and has emerged as a significant player in AD and other neurodegenerative diseases [5,6,7] as well as a promising therapeutic target [8,9]. Here, TREM2 is linked to Alzheimer disease.